INDIANAPOLIS (WISH) — In this week’s “Morning Checkup,” WISH-TV Medical Expert Dr. Janel Gordon shares an update on the growing weight loss drug market.

Lilly’s Zepbound

Lilly’s Zepbound direct-to-consumer cash-pay option is now available in a prefilled multi-use fixed-dose Kwikpen. Patients will not have to draw up the medicine from a vial using a syringe for their weekly dose. There is no change in price. This direct-to-consumer option was initially introduced for individuals without insurance, or for those who, even with insurance, the cost of medication is too high.

Hims & Hers

Days after launching a new compounded semaglutide weight loss pill, national telemedicine platform Hims & Hers has pulled the...